Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts.
(Q43170366)
scientific article published on 6 February 2010
scientific article published on 6 February 2010
Language:
Current Data About
Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts.
other details
| description | scientific article published on 6 February 2010 |
External Links
| (P356) |
10.1016/J.LEUKRES.2010.01.015
|
| (P698) |
20138667
|